Therapure BioPharma, Inc. has been selected by LFB Biotechnologies, a subsidiary of LFB SA, for the development of a manufacturing method for a plasma therapeutic protein. Therapure will develop a manufacturing process for the large-scale production of a biologic for clinical trials. R&D teams from both companies will manage the project. The potential treatment is for a serious illness that currently has limited treatment options, according to a joint statement. “We are pleased that LFB ...